TaxxaCompany Logo

Menu

Company

About usCareersBlogContact usLinkedInYouTube

Product

FeaturesPricingFAQ

Legal

Cookie PolicyData Processing AgreementPrivacy PolicyTerms and Conditions
© 2026 Taxxa AI Oy. All rights reserved.
  1. News
  2. /United Kingdom
  3. /Legal & Corporate

United Kingdom·GOV.UK

CMA launches Phase 1 inquiry into Vivisol / Air Liquide deal

The CMA has launched its Phase 1 inquiry into the Vivisol / Air Liquide home oxygen deal, with a 19 November 2026 decision deadline and third-party comments due by 1 October 2026.

By Taxxa AI Oy · Published 24 September 2026

Legal & Corporate

The Competition and Markets Authority has launched its Phase 1 merger inquiry into the Vivisol / Air Liquide home oxygen services business transaction, announcing the launch by notice to the parties on 24 September 2026. A commencement notice dated 24 September 2026 is published alongside the announcement. The statutory timetable sets 19 November 2026 as the deadline for the Phase 1 decisionGOV, although the CMA notes it will seek to determine its investigation as quickly as possible and that the statutory deadline can be extended in certain limited circumstances.

Interested parties — including competitors, customers and suppliers of home oxygen services — have until 1 October 2026 to submit initial viewsGOV. The invitation to comment, which runs from 11 August 2026 to 1 October 2026, is the first part of the CMA's information-gathering process: it allows interested parties to submit views on the impact the transaction could have on competition in the UK. Written representations about any competition issues should be provided by the deadline set out in the timetable.

The timetable firms up what was previously provisional. The case page formerly listed the Phase 1 decision deadline and the inquiry launch as TBC, with the invitation to comment closing in late September 2026, and stated that the CMA had not yet launched its formal investigation into the transaction. On pre-notification, the page records that the CMA has received the necessary information from the parties to commence pre-notification.

Representations should be sent to vivisol.airliquidehomeoxygen@cma.gov.uk, and the page now names a principal case officer, Hannah Street. Anyone submitting views should expect the CMA to use their name and contact details as personal data: the authority processes them so it can contact contributors again for further help or information in order to carry out its merger work under Part 3 of the Enterprise Act 2002, with further detail in its personal information charter.

Legal basis: Enterprise Act 2002 Part 3.

Send written representations on the Vivisol / Air Liquide transaction to vivisol.airliquidehomeoxygen@cma.gov.uk by 1 October 2026.

Sources

  1. Vivisol / Air Liquide (home oxygen services business) merger inquiry

Share with your network

More on this

  1. 22 Sept 2026

    Director owes £190,154 as court limits section 212 to duty breaches

  2. 18 Sept 2026

    Insolvent-company name ban widens to similar names and new sellers

  3. 18 Sept 2026

    Directors warned HMRC may seek bankruptcy over unpaid Self Assessment tax

  4. 17 Sept 2026

    Overseas companies must post AA01 date-change form to Companies House

  5. 16 Sept 2026

    CMA launches McCormick/Unilever phase 1 inquiry; decision due 11 November

United Kingdom news